<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>SOCS4 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>SOCS4</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q8WXH5" target="_blank" class="term-link">
                        Q8WXH5
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-draft">
                    DRAFT
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">Suppressor of cytokine signaling 4</span>
                    
                    <span class="badge">SOCS-4</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "SOCS4";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q8WXH5" data-a="DESCRIPTION: Suppressor of cytokine signaling 4 (SOCS4, ~50 kDa..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>Suppressor of cytokine signaling 4 (SOCS4, ~50 kDa), member of SOCS family serving as STAT-induced inhibitor and negative feedback regulator in cytokine and growth factor signaling. Contains central SH2 domain (binds phosphotyrosine) and C-terminal SOCS box (recruits E3 ubiquitin ligase machinery). Long N-terminal region (~270 aa) characteristic of SOCS4-7 subfamily. Functions as E3 ligase adaptor: SH2 domain binds specific phosphotyrosine motifs on activated receptors/kinases, while SOCS box recruits Elongin B/C-Cullin-5 ubiquitin ligase complex, promoting proteasomal degradation of bound substrates. Primary target is EGFR - binds phospho-Y1092 on activated EGFR, recruiting ubiquitin ligase for receptor degradation and blocking STAT3 binding site, thereby attenuating EGF-induced signaling. Acts as brake on growth factor receptor signaling by physically associating with and marking activated proteins for destruction. Also reported weak interactions with c-Kit receptor and JAK2. Critical role in limiting inflammatory responses during infection - SOCS4-knockout mice highly susceptible to influenza with exaggerated cytokine storm (excessive chemokines/cytokines causing tissue damage). Tempers initial wave of inflammation preventing immune-mediated damage. Human SOCS4 T266M mutation causes autoimmune/inflammatory syndrome via hyperactive EGFR-STAT3 signaling. Acts as tumor suppressor in some cancers (gastric, lung) where loss removes brake on EGFR/STAT3 oncogenic pathways. Cytosolic protein recruited to activated receptor complexes at plasma membrane or endosomes. Broadly expressed with inducible upregulation by cytokines/growth factors. Dispensable for baseline development but crucial during acute stress responses.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019221" target="_blank" class="term-link">
                                    GO:0019221
                                </a>
                            </span>
                            <span class="term-label">cytokine-mediated signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0019221" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> SOCS4 is induced by cytokines and acts as a negative feedback regulator in cytokine signaling pathways. While SOCS4 is part of the SOCS family which regulates cytokine signaling, its primary characterized function is EGFR regulation rather than direct JAK/STAT inhibition like SOCS1/3. The deep research shows SOCS4 can modulate cytokine responses indirectly through EGFR/STAT3 cross-talk and is critical for preventing cytokine storms during infection.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> SOCS4 clearly functions in cytokine-mediated signaling pathways as demonstrated by influenza infection studies showing SOCS4-KO mice have exaggerated cytokine storm and dysregulated chemokine production. IBA phylogenetic inference is well-supported by experimental data showing SOCS4 is induced by cytokines and regulates inflammatory responses. This is a core biological process for SOCS4.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    SOCS4-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Mice lacking the Socs4 gene were found to be highly susceptible to influenza, suffering more severe disease compared to wild-type mice. SOCS4-knockout mice infected with H1N1 influenza showed an exaggerated inflammatory response in the lungs ‚Äì often termed a &#39;cytokine storm&#39; ‚Äì characterized by excessive production of pro-inflammatory chemokines and cytokines that led to tissue damage.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009968" target="_blank" class="term-link">
                                    GO:0009968
                                </a>
                            </span>
                            <span class="term-label">negative regulation of signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0009968" data-r="GO_REF:0000043" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This term is too broad and uninformative. SOCS4 does negatively regulate signal transduction, but this annotation provides no specificity about which pathways or mechanisms. More specific terms like GO:0007175 (negative regulation of EGFR activity) or GO:0032436 (positive regulation of proteasomal degradation) better capture SOCS4&#39;s actual molecular function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct, this term is too general to be useful. SOCS4&#39;s specific mechanism is to promote ubiquitin-mediated degradation of activated receptors, particularly EGFR. The more specific child terms already present in the annotation set (GO:0007175, GO:0032436) provide better functional information. This should be replaced with more specific regulatory terms or removed as redundant.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050730" target="_blank" class="term-link">
                                    regulation of peptidyl-tyrosine phosphorylation
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051898" target="_blank" class="term-link">
                                    negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032436" target="_blank" class="term-link">
                                    GO:0032436
                                </a>
                            </span>
                            <span class="term-label">positive regulation of proteasomal ubiquitin-dependent protein catabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0032436" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> SOCS4 functions as an E3 ubiquitin ligase adaptor. Its SOCS box domain recruits the Elongin B/C-Cullin-5 ubiquitin ligase complex to targets bound by its SH2 domain (particularly phosphorylated EGFR), promoting their polyubiquitination and proteasomal degradation. This is well-established by structural studies and functional experiments.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation accurately captures SOCS4&#39;s core molecular mechanism. The crystal structure of SOCS4-Elongin B/C complex (PMID:17997974) demonstrates how SOCS box recruits ubiquitination machinery. Deep research confirms SOCS4 promotes EGFR degradation through this mechanism. This is a fundamental aspect of SOCS4 function and merits acceptance despite IEA evidence code.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    SOCS4-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">Once bound, the C-terminal SOCS box recruits an E3 ubiquitin ligase complex: the SOCS box interacts with the adaptor proteins Elongin B and Elongin C, which in turn couple SOCS4 to a Cullin-5/RING ubiquitin ligase scaffold. This SOCS4‚ÄìElongin-Cullin complex catalyzes the polyubiquitination of the associated target protein, marking it for proteasomal degradation.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/SOCS4/SOCS4-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035556" target="_blank" class="term-link">
                                    GO:0035556
                                </a>
                            </span>
                            <span class="term-label">intracellular signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0035556" data-r="GO_REF:0000002" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This term is extremely broad and uninformative. While SOCS4 does participate in intracellular signal transduction by modulating receptor signaling, this high-level process term provides minimal functional information. More specific child terms already annotated (cytokine signaling, EGFR regulation) are far more informative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is at the wrong level of granularity - too general to be useful. SOCS4&#39;s role is specifically as a negative regulator targeting receptor tyrosine kinases (particularly EGFR) and modulating STAT signaling. The term &#34;intracellular signal transduction&#34; could apply to thousands of proteins. Should be replaced with more specific regulatory terms that capture SOCS4&#39;s actual mechanism and pathway involvement.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0038128" target="_blank" class="term-link">
                                    ERBB2 signaling pathway
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007169" target="_blank" class="term-link">
                                    cell surface receptor protein tyrosine kinase signaling pathway
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25814554
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phospho-tyrosine dependent protein-protein interaction netwo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:25814554" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents protein-protein interaction with FRS3 (O43559) from a phosphotyrosine-dependent interaction screen. While this is experimental evidence for protein binding, the term &#34;protein binding&#34; alone is uninformative and should be avoided per curation guidelines.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Per curation guidelines: &#34;Avoid the term protein binding, this doesn&#39;t tell us anything about the actual function.&#34; While PMID:25814554 provides experimental evidence for SOCS4 binding to FRS3, the annotation should use more specific molecular function terms. SOCS4&#39;s SH2 domain binds phosphotyrosine residues, so &#34;phosphotyrosine residue binding&#34; (GO:0001784) or &#34;SH2 domain binding&#34; (GO:0042169) would be more informative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042169" target="_blank" class="term-link">
                                    SH2 domain binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25814554
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phospho-tyrosine dependent protein-protein interaction netwo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:25814554" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents protein-protein interaction with GRB2 (P62993) from PMID:25814554. This is a duplicate GO term (same PMID, different interacting partner). While experimentally validated, &#34;protein binding&#34; is too vague per curation guidelines.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same issue as previous protein binding annotation. SOCS4&#39;s interaction with GRB2 (an SH2/SH3 adaptor protein) likely involves phosphotyrosine-mediated binding through SOCS4&#39;s SH2 domain. Should use more specific molecular function terms that describe the binding mechanism rather than generic &#34;protein binding&#34;.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042169" target="_blank" class="term-link">
                                    SH2 domain binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25814554
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phospho-tyrosine dependent protein-protein interaction netwo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:25814554" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents protein-protein interaction with PIK3R3 (Q92569) from PMID:25814554. Third duplicate of generic protein binding term from same phosphotyrosine interaction screen.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same rationale as above - &#34;protein binding&#34; is too uninformative. PIK3R3 is the p55gamma regulatory subunit of PI3K, which also contains SH2 domains. SOCS4&#39;s interaction likely involves phosphotyrosine recognition. More specific molecular function terms should be used.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042169" target="_blank" class="term-link">
                                    SH2 domain binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25814554
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phospho-tyrosine dependent protein-protein interaction netwo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:25814554" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents interaction with RBP7 (Q96R05) from PMID:25814554. Fourth instance of generic protein binding from same study.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Continuing pattern - all these PMID:25814554 annotations should be consolidated under more specific molecular function terms like phosphotyrosine binding rather than multiple redundant &#34;protein binding&#34; entries.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25814554
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Phospho-tyrosine dependent protein-protein interaction netwo...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:25814554" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents interaction with PINK1 (Q9BXM7) from PMID:25814554. Fifth instance from same phosphotyrosine interaction screen.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same issue - multiple redundant &#34;protein binding&#34; annotations from a single high-throughput screen should be replaced with one or more specific molecular function terms that describe SOCS4&#39;s actual binding mechanism (SH2-mediated phosphotyrosine recognition).
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32296183" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents interaction with TEKT4 (Q8WW24) from PMID:32296183 (binary protein interactome reference map). TEKT4 is a testis-specific tektin involved in sperm flagella. This interaction seems unlikely to be functionally relevant to SOCS4&#39;s core role in receptor tyrosine kinase regulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-throughput binary interaction data from PMID:32296183 often includes false positives or non-physiological interactions. TEKT4 is testis-specific cytoskeletal protein with no obvious functional connection to SOCS4&#39;s role in EGFR/cytokine signaling. Even if interaction is real, generic &#34;protein binding&#34; annotation is uninformative. Should use specific molecular function term if mechanism is known, or mark as non-core interaction.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation documents interaction with DMWD (G5E9A7) from PMID:32814053 (neurodegenerative disease interactome study). DMWD is involved in myotonic dystrophy. Unclear functional relevance to SOCS4.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Another high-throughput study (neurodegenerative disease proteins) with questionable functional relevance. Generic &#34;protein binding&#34; provides no useful functional information. Should be replaced with specific molecular function term or marked as peripheral/non-core.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with BSCL2 (J3KQ12) from neurodegenerative disease interactome. BSCL2/seipin is involved in lipid droplet formation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same issues - high-throughput data, unclear functional relevance, uninformative generic term. Should use specific molecular function terms.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with SPTLC1 isoform (O15269-2) from PMID:32814053. SPTLC1 is serine palmitoyltransferase involved in sphingolipid biosynthesis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Neurodegenerative disease interactome data with no clear connection to SOCS4&#39;s known functions. Generic term uninformative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with HTRA2 (O43464) from PMID:32814053. HTRA2 is a mitochondrial serine protease involved in apoptosis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-throughput neurodegenerative disease study. Unclear functional relevance. Generic term uninformative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with GARS1 (P41250) from PMID:32814053. GARS1 is glycyl-tRNA synthetase.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-throughput study with no functional context. Generic &#34;protein binding&#34; uninformative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with HTT/huntingtin (P42858) from neurodegenerative disease interactome. HTT is the protein mutated in Huntington&#39;s disease.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> From neurodegenerative disease focused screen. While potentially interesting, generic &#34;protein binding&#34; term is uninformative and should be replaced with specific molecular function.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with SPRED1 (Q7Z699) from PMID:32814053. SPRED1 is a negative regulator of MAPK/ERK signaling. This interaction is more plausible functionally since both proteins negatively regulate RTK signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this interaction with SPRED1 has better functional plausibility (both are RTK signaling inhibitors), the generic &#34;protein binding&#34; term remains uninformative. Should use specific molecular function term.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with JPH3 (Q8WXH2) from PMID:32814053. JPH3/junctophilin-3 is involved in junctional membrane complexes, implicated in Huntington&#39;s disease-like 2.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Neurodegenerative disease interactome with unclear functional connection to SOCS4 biology. Generic term uninformative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32814053
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Interactome Mapping Provides a Network of Neurodegenerative ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0005515" data-r="PMID:32814053" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Interaction with PANK2 isoform (Q9BZ23-2) from PMID:32814053. PANK2 is pantothenate kinase involved in CoA biosynthesis.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> High-throughput neurodegenerative disease study. No clear functional connection. Generic term uninformative.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                                    phosphotyrosine residue binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016567" target="_blank" class="term-link">
                                    GO:0016567
                                </a>
                            </span>
                            <span class="term-label">protein ubiquitination</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000041
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0016567" data-r="GO_REF:0000041" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> SOCS4 promotes protein ubiquitination by serving as an adaptor that recruits E3 ubiquitin ligase machinery (Elongin B/C-Cullin-5) to bound substrates like activated EGFR. This is a core aspect of SOCS4&#39;s mechanism of action.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this is IEA (inferred from UniPathway), it accurately represents SOCS4&#39;s established molecular function. The SOCS box domain recruits ubiquitin ligase complexes to promote degradation of receptor targets. This is well-supported by structural and functional studies showing SOCS4-mediated EGFR ubiquitination and degradation. Core mechanism annotation that should be retained.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    SOCS4-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin ligase complexes. This SOCS4‚ÄìElongin-Cullin complex catalyzes the polyubiquitination of the associated target protein, marking it for proteasomal degradation.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/SOCS4/SOCS4-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">PATHWAY: Protein modification; protein ubiquitination.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007175" target="_blank" class="term-link">
                                    GO:0007175
                                </a>
                            </span>
                            <span class="term-label">negative regulation of epidermal growth factor-activated receptor activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15590694" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:15590694
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Suppressors of cytokine signaling 4 and 5 regulate epidermal...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WXH5" data-a="GO:0007175" data-r="PMID:15590694" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is the primary, best-characterized function of SOCS4. PMID:15590694 experimentally demonstrates that SOCS4 and SOCS5 negatively regulate EGFR signaling. SOCS4&#39;s SH2 domain binds phospho-Y1092 on activated EGFR, recruiting ubiquitin ligase machinery for receptor degradation while simultaneously blocking STAT3 binding to that site.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the gold-standard annotation for SOCS4 - experimental IDA evidence from the seminal paper characterizing SOCS4/5 function in EGFR regulation. Deep research confirms EGFR is the primary characterized target of SOCS4. UniProt function section emphasizes EGFR degradation. This represents SOCS4&#39;s core molecular function and should be retained as a cornerstone annotation. Well-supported by structural studies (PMID:17997974) and functional validation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    SOCS4-deep-research-openai.md
                                    
                                </span>
                                
                                <div class="support-text">A defining target of SOCS4 is the Epidermal Growth Factor Receptor (EGFR), a receptor tyrosine kinase. SOCS4 was shown to bind directly to a particular phosphotyrosine site on the activated EGFR (tyrosine 1092 in the human EGFR cytoplasmic domain) via its SH2 domain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Phosphotyrosine-dependent ubiquitin ligase adaptor activity targeting activated EGFR for proteasomal degradation</h3>
                <span class="vote-buttons" data-g="Q8WXH5" data-a="FUNCTION: Phosphotyrosine-dependent ubiquitin ligase adaptor..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001784" target="_blank" class="term-link">
                            phosphotyrosine residue binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007175" target="_blank" class="term-link">
                                negative regulation of epidermal growth factor-activated receptor activity
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032436" target="_blank" class="term-link">
                                positive regulation of proteasomal ubiquitin-dependent protein catabolic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016567" target="_blank" class="term-link">
                                protein ubiquitination
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019221" target="_blank" class="term-link">
                                cytokine-mediated signaling pathway
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                cytoplasm
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">In Complex:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031466" target="_blank" class="term-link">
                            Cul5-RING ubiquitin ligase complex
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Substrates:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.uniprot.org/uniprotkb/P00533" target="_blank" class="term-link">
                                EGFR
                            </a>
                        </span>
                        
                    </div>
                </div>
                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/15590694" target="_blank" class="term-link">
                                PMID:15590694
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">SOCS4 binds directly to phosphotyrosine 1092 on activated EGFR via its SH2 domain, competing with STAT3 for this binding site and promoting EGFR degradation</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/17997974" target="_blank" class="term-link">
                                PMID:17997974
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">Crystal structure reveals SOCS4 SOCS box domain recruits Elongin B/C complex, forming E3 ubiquitin ligase machinery that targets bound substrates for proteasomal degradation</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            SOCS4-deep-research-openai.md
                            
                        </span>
                        
                        <div class="finding-text">SOCS4&#39;s SH2 domain recognizes specific phosphotyrosine motifs on activated EGFR (Y1092), while SOCS box recruits Elongin B/C-Cullin-5 ubiquitin ligase complex, catalyzing polyubiquitination and proteasomal degradation of EGFR. This dual mechanism both blocks STAT3 binding and promotes receptor turnover</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/SOCS4/SOCS4-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">Substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Inhibits EGF signaling by mediating the degradation of the Tyr-phosphorylated EGF receptor/EGFR</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000041.md" target="_blank" class="term-link">
                            GO_REF:0000041
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniPathway vocabulary mapping.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15590694" target="_blank" class="term-link">
                            PMID:15590694
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25814554" target="_blank" class="term-link">
                            PMID:25814554
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Phospho-tyrosine dependent protein-protein interaction network.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32814053" target="_blank" class="term-link">
                            PMID:32814053
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(SOCS4-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8WXH5" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-03T23:06:00.377550'<br />
end_time: '2025-11-03T23:06:00.378529'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q8WXH5<br />
  gene_symbol: SOCS4<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 79</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene SOCS4 (Q8WXH5) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="socs4-suppressor-of-cytokine-signaling-4-functions-pathways-and-localization">SOCS4 (Suppressor of Cytokine Signaling 4) ‚Äì Functions, Pathways, and Localization</h1>
<h2 id="overview-and-key-characteristics-of-socs4">Overview and Key Characteristics of SOCS4</h2>
<p><strong>SOCS4 (Suppressor of Cytokine Signaling 4)</strong> is a human protein (~50 kDa) encoded by the <em>SOCS4</em> gene (UniProt Q8WXH5). It belongs to the SOCS family of proteins, which are <strong>STAT-induced inhibitors</strong> acting as inducible negative feedback regulators in cytokine and growth factor signaling pathways (<a href="https://en.wikipedia.org/wiki/SOCS4#:~:text=The%20protein%20encoded%20by%20this,been%20found%20for%20this%20gene">en.wikipedia.org</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=SOCS%20proteins%20are%20essential%20for,Therefore%2C%20this%20review%20aims%20to">pubmed.ncbi.nlm.nih.gov</a>). Like other SOCS members, SOCS4 contains a central <strong>SH2 domain</strong> (Src homology 2) and a C-terminal <strong>SOCS box</strong> motif (<a href="https://en.wikipedia.org/wiki/SOCS4#:~:text=The%20protein%20encoded%20by%20this,been%20found%20for%20this%20gene">en.wikipedia.org</a>). The SH2 domain specifically binds phosphorylated tyrosine residues on target proteins, while the SOCS box recruits ubiquitination machinery, defining the SOCS proteins‚Äô role as adaptors for proteasomal degradation of signaling molecules (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kamura%2C%20T,Genes%20%26%20Development%2012%3A3872%E2%80%933881">ngdc.cncb.ac.cn</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>). SOCS4 and the related SOCS5‚Äì7 have unusually long <strong>N-terminal regions</strong> (in SOCS4, ~270 amino acids) not found in the smaller SOCS1‚Äì3, suggesting these proteins may engage additional interactions or regulatory mechanisms beyond the core SH2/SOCS-box function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=tempting%20to%20extrapolate%20this%20well,growth%20factor%20receptor%20signalling%20via">pmc.ncbi.nlm.nih.gov</a>). Bioinformatic analyses indicate the N-terminus of SOCS4 is largely disordered (except for a ~70-residue segment), and its precise role remains unclear (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20contains%20a%20considerably%20longer,role%20in%20the%20mediating%20epidermal">www.frontiersin.org</a>). Notably, SOCS4 and SOCS5 share a conserved N-terminal subregion, though this region appears to play only a minor role in their known signaling functions (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20contains%20a%20considerably%20longer,EGFR">www.frontiersin.org</a>).</p>
<p><strong>Subcellular localization:</strong> SOCS4 is a cytosolic protein that functions at the intracellular side of receptor signaling complexes. It lacks any transmembrane domain or signal peptide, and is generally found in the <strong>cytoplasm</strong>, where it can interact with activated receptors or kinases. Upon cytokine or growth factor stimulation, SOCS4 is induced and recruited to activated receptor complexes in the cell, such as the cytoplasmic tail of the <strong>Epidermal Growth Factor Receptor (EGFR)</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to">pmc.ncbi.nlm.nih.gov</a>). By binding to receptors at the plasma membrane or in endosomal vesicles, SOCS4 exerts its regulatory effect locally at those signaling sites. Transcript profiling indicates <em>SOCS4</em> is <strong>broadly expressed</strong> in human tissues (with detectable mRNA in lymphoid organs like appendix and lymph node, among others) (<a href="https://www.ncbi.nlm.nih.gov/gene/122809#:~:text=Expression%20Ubiquitous%20expression%20in%20appendix,25%20other%20tissues%20See%20more">www.ncbi.nlm.nih.gov</a>), consistent with a general role in modulating cytokine and growth factor responses across multiple cell types. In summary, SOCS4 is a cytosolic adaptor protein characterized by an SH2 domain for target binding and a SOCS box for ubiquitin ligase recruitment, positioning it as a negative regulator of signaling pathways.</p>
<h2 id="mechanism-of-action-sh2-domain-socs-box-and-ubiquitin-mediated-regulation">Mechanism of Action: SH2 Domain, SOCS Box, and Ubiquitin-Mediated Regulation</h2>
<p><strong>Domain structure and mechanism:</strong> SOCS4‚Äôs mode of action centers on its ability to <strong>bind phosphorylated signaling proteins and target them for ubiquitination and degradation</strong>. The SH2 domain of SOCS4 recognizes specific phosphotyrosine motifs on target proteins (often activated receptors or signaling enzymes), tethering SOCS4 to these signaling complexes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to">pmc.ncbi.nlm.nih.gov</a>). Once bound, the C-terminal SOCS box recruits an E3 ubiquitin ligase complex: the SOCS box interacts with the adaptor proteins Elongin B and Elongin C, which in turn couple SOCS4 to a Cullin-5/RING ubiquitin ligase scaffold (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kamura%2C%20T,Genes%20%26%20Development%2012%3A3872%E2%80%933881">ngdc.cncb.ac.cn</a>). This <strong>SOCS4‚ÄìElongin-Cullin complex</strong> catalyzes the polyubiquitination of the associated target protein, marking it for proteasomal degradation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>). A seminal structural study in 2007 resolved the crystal structure of a SOCS4‚ÄìElongin B/C complex, revealing the details of this interface and confirming the molecular basis by which SOCS4 recruits the ubiquitin machinery to degrade bound substrates (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Bullock%2C%20A,PMID%3A%2017997974">ngdc.cncb.ac.cn</a>). In essence, SOCS4 functions as an <strong>E3 ligase adaptor</strong>: it itself is not an enzyme, but it brings ubiquitin-transfer enzymes into proximity with specific phosphorylated targets, thereby attenuating signaling by promoting the <strong>turnover of activated receptors or signaling proteins</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Target recognition and specificity:</strong> A defining target of SOCS4 is the <strong>Epidermal Growth Factor Receptor (EGFR)</strong>, a receptor tyrosine kinase. SOCS4 was shown to bind directly to a particular phosphotyrosine site on the activated EGFR (tyrosine 1092 in the human EGFR cytoplasmic domain) via its SH2 domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to">pmc.ncbi.nlm.nih.gov</a>). This interaction is phosphorylation-dependent ‚Äì SOCS4 docks onto EGFR only after the receptor is activated and autophosphorylated on Y1092 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to">pmc.ncbi.nlm.nih.gov</a>). Binding of SOCS4 to EGFR has two major consequences: (1) it <strong>recruits the ubiquitin ligase complex</strong> to EGFR, leading to ubiquitination and <strong>proteasomal degradation of the receptor</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>), and (2) it <strong>blocks downstream signaling</strong> by occluding access of other signaling molecules to that phosphotyrosine site. In particular, the same Y1092 on EGFR is a docking site for STAT3, a transcription factor activated by EGFR signaling; by occupying Y1092, SOCS4 prevents STAT3 from binding and becoming activated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the">pmc.ncbi.nlm.nih.gov</a>). Through these mechanisms, SOCS4 effectively <strong>attenuates EGF-induced signaling</strong>, reducing both the duration and intensity of downstream pathways (such as the STAT3 pathway) emanating from EGFR (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to">pmc.ncbi.nlm.nih.gov</a>). This ability to <strong>compete for receptor binding sites and induce receptor degradation</strong> is a hallmark of SOCS4‚Äôs function.</p>
<p>It‚Äôs worth noting that SOCS4‚Äôs close relative SOCS5 can also downregulate EGFR, though via a slightly different mechanism: SOCS5‚Äôs long N-terminal region can interact with EGFR even in the absence of phosphorylation, whereas SOCS4 relies on phosphotyrosine binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,Y1092%29%20as%20STAT3%3B%20therefore">pmc.ncbi.nlm.nih.gov</a>). Both SOCS4 and SOCS5 ultimately promote EGFR degradation, and together they are unique among SOCS family members in significantly reducing cellular EGFR levels when overexpressed (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L865%20SOCS4%20and,KO%7D%20mice%20and">www.frontiersin.org</a>). The <strong>specificity of SOCS4‚Äôs SH2 domain</strong> appears tuned mainly to certain receptor tyrosine kinases; besides EGFR, SOCS4 has been reported (from in vitro assays) to bind with lower affinity to the activated c-Kit receptor (stem cell factor receptor) and to JAK2 (a Janus kinase) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=ubiquitin%20ligase%20activity%20,141%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>). The biological significance of these latter interactions is still undetermined, but they suggest SOCS4 could have broader substrate scope, potentially modulating <strong>c-Kit signaling</strong> (implicated in hematopoietic and reproductive physiology) or certain <strong>JAK/STAT pathways</strong> in specific contexts (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=ubiquitin%20ligase%20activity%20,141%5D.%20SOCS5">pmc.ncbi.nlm.nih.gov</a>). Overall, the primary mechanism of SOCS4 is to <strong>serve as a brake on signal transduction</strong> by physically associating with activated signaling proteins and marking them for destruction, thereby curtailing the propagation of the signal.</p>
<h2 id="biological-function-and-pathways-involving-socs4">Biological Function and Pathways Involving SOCS4</h2>
<h3 id="regulation-of-egfr-and-growth-factor-signaling">Regulation of EGFR and Growth Factor Signaling</h3>
<p>One of the best-characterized functions of SOCS4 is its role in <strong>negative regulation of epidermal growth factor (EGF) receptor signaling</strong>. Initial studies demonstrated that SOCS4 (and SOCS5) can downregulate EGF-induced signaling in cells (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kario%2C%20E,PMID%3A%2015590694">ngdc.cncb.ac.cn</a>). Mechanistically, as described above, SOCS4 binding to EGFR leads to receptor ubiquitination and degradation, effectively <strong>reducing EGFR protein levels</strong> and dampening downstream pathways like the STAT3 transcriptional program (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,KIT%2C%20the">pmc.ncbi.nlm.nih.gov</a>). Because EGFR activation influences cell proliferation, survival, and differentiation, SOCS4 is thought to act as a <strong>safety check on growth factor signals</strong>. By competing with STAT3 for receptor binding, SOCS4 can directly inhibit STAT3 activation in response to EGF (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the">pmc.ncbi.nlm.nih.gov</a>). This places SOCS4 as an important modulator in pathways where EGFR‚ÄìSTAT3 signaling drives functional outcomes (for example, in epithelial cell growth or inflammation). Consistent with this, an experimental study in <strong>zebrafish</strong> (which possess two SOCS4 paralogs) lent further support to SOCS4‚Äôs role in EGF signaling: zebrafish <em>socs4b</em> mutant fish developed normally (indicating SOCS4 is not essential for development), but <em>in vitro</em> assays showed that the Socs4b protein can attenuate <strong>EGF-induced signaling</strong> through the EGFR pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11430285/#:~:text=vivo%20and%20in%20vitro,able%20to%20regulate%20EGFR%20signaling">pmc.ncbi.nlm.nih.gov</a>). This suggests that under physiological conditions, SOCS4 acts redundantly or is only needed under stress, yet it clearly has the capacity to regulate receptor tyrosine kinase signals when present. Indeed, some authors propose that whereas SOCS1‚Äì3 primarily target cytokine-JAK/STAT pathways, the subgroup SOCS4‚Äì7 predominantly <strong>regulate receptor tyrosine kinases (RTKs)</strong> (like EGFR, c-Kit, insulin receptor, etc.), highlighting SOCS4 as part of the cellular machinery controlling growth factor receptor signaling intensity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=research%20evidence%20suggesting%20that%20while,and%20RTKs%20is%20not%20strict">pmc.ncbi.nlm.nih.gov</a>).</p>
<p>Beyond EGFR, SOCS4‚Äôs potential interactions with other RTKs or signaling proteins hint at additional roles. Its <strong>weak affinity for c-Kit</strong> (the receptor for stem cell factor) is intriguing in light of a reported function in ovarian biology: SOCS4 has been implicated as a <strong>modulator of primordial follicle activation in the ovary</strong> (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Russell%2C%20and%20E,PMID%3A%2021604262">ngdc.cncb.ac.cn</a>). In the mouse ovary, c-Kit signaling in oocytes is one pathway that drives the transition of dormant primordial follicles into maturing follicles. A study found that SOCS4 is expressed in ovarian tissue and suggested it acts as a ‚Äú<strong>gate-keeper</strong>‚Äù to restrain premature follicle activation (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Russell%2C%20and%20E,PMID%3A%2021604262">ngdc.cncb.ac.cn</a>). While the exact mechanism in that context wasn‚Äôt fully confirmed, it is plausible that SOCS4 tempers c-Kit or other growth factor signals in the ovary, thereby preventing excessive or untimely follicular development. This example illustrates how SOCS4‚Äôs basic biochemical function ‚Äì dampening RTK signaling ‚Äì can translate into a specific physiological role (maintenance of the ovarian reserve). Similarly, <strong>insulin and IGF signaling</strong> are other RTK pathways where SOCS family members play roles (e.g., SOCS6/7 in metabolic regulation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=Like%20other%20SOCS%20proteins%2C%20SOCS6,to%20bind%20to%20and%20inhibit">pmc.ncbi.nlm.nih.gov</a>)), although SOCS4 itself has not been strongly linked to insulin pathways. In summary, <strong>SOCS4‚Äôs primary function is as a negative regulator of growth factor receptors</strong>, with EGFR being the clearest example to date. By ensuring proper termination of EGFR/STAT3 signals, SOCS4 contributes to controlled cell growth and balanced signaling outputs in tissues.</p>
<h3 id="role-in-cytokine-signaling-and-immune-pathways">Role in Cytokine Signaling and Immune Pathways</h3>
<p>Although named for cytokine signaling, SOCS4 is less studied in classical JAK/STAT cytokine pathways than SOCS1‚Äì3. SOCS4 does <strong>not directly bind and inhibit JAK kinases</strong> with high affinity (unlike SOCS1 and SOCS3, which bind JAKs), but it can influence cytokine signaling indirectly through its impact on receptors and downstream molecules. For instance, by targeting EGFR and limiting STAT3 activation, SOCS4 may affect cytokine-driven STAT3 responses (since many cytokines like IL-6 also activate STAT3). There is evidence that SOCS4 can modulate certain cytokine pathways <em>via</em> cross-talk: one study found that <strong>infection with the parasite <em>Cryptosporidium</em></strong> in intestinal cells induces microRNAs (miR-98 and let-7) that downregulate SOCS4, leading to prolonged IL-6/STAT3 signaling in those cells (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Hu%2C%20G,PMID%3A%2020486857">ngdc.cncb.ac.cn</a>). This suggests that in some immune contexts, SOCS4 would normally act to curb pro-inflammatory cytokine signaling, but pathogens may suppress SOCS4 to promote a stronger host cell response (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Hu%2C%20G,PMID%3A%2020486857">ngdc.cncb.ac.cn</a>). Indeed, the SOCS family in general is induced by cytokines as a <strong>negative feedback loop</strong>, and SOCS4 is no exception ‚Äì stimuli such as interferons or interleukins can upregulate <em>SOCS4</em> expression, which then feeds back to dampen signaling cascades (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=The%20expression%20of%20SOCS%20proteins,talk.%E2%80%9D">pmc.ncbi.nlm.nih.gov</a>). However, compared to SOCS1 or SOCS3, the <strong>precise cytokine triggers</strong> and direct molecular targets of SOCS4 in immune signaling are not well defined. Some in vitro data suggest SOCS4 can weakly inhibit certain cytokine receptor pathways (e.g. interferon-Œ≥ or IL-4 signaling) when overexpressed, but these effects are subtle relative to the potent inhibition by SOCS1/3 in those pathways (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=biological%20consequences%20of%20which%20remain,119%20%2C%20%20138">pmc.ncbi.nlm.nih.gov</a>). Thus, <strong>SOCS4‚Äôs role in cytokine signaling appears more auxiliary or context-dependent</strong>, often manifesting through cross-regulation of pathways like EGFR‚ÄìSTAT3 that interface with cytokine networks.</p>
<h3 id="immune-response-infection-and-inflammation">Immune Response, Infection, and Inflammation</h3>
<p>Emerging research has uncovered an important role for SOCS4 in controlling <strong>innate immune responses during infections</strong>, even though it is not a classical immune cell signaling molecule like SOCS1/3. A striking example comes from studies of <strong>influenza A virus infection</strong>. Mice lacking the <em>Socs4</em> gene were found to be <strong>highly susceptible to influenza</strong>, suffering more severe disease compared to wild-type mice (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>). SOCS4-knockout mice infected with H1N1 influenza showed an <strong>exaggerated inflammatory response</strong> in the lungs ‚Äì often termed a ‚Äúcytokine storm‚Äù ‚Äì characterized by <strong>excessive production of pro-inflammatory chemokines and cytokines</strong> that led to tissue damage (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>). In these animals, the early innate immune response was dysregulated: levels of key chemokines in the lung (important for recruiting immune cells) were abnormally high, and the mice failed to effectively clear the virus, resulting in increased mortality (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>). This phenotype indicates that SOCS4 normally acts to <strong>temper the initial wave of inflammation</strong> during viral infection, preventing immune-mediated damage while still allowing virus control. Indeed, the absence of SOCS4 skews the balance toward immunopathology (too much inflammation) at the expense of efficient viral clearance (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L277%202014,PMID%3A%2024809749">ngdc.cncb.ac.cn</a>). Consistent with this, delivering exogenous SOCS4 can have protective effects: in one study, a recombinant herpesvirus engineered to express SOCS4 was used in a mouse cytokine storm model, and the presence of SOCS4 helped <strong>protect against lethal inflammation</strong>, highlighting its potential as an anti-inflammatory agent (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L641%20Ren%2C%20S,PMID%3A%2030569160">ngdc.cncb.ac.cn</a>).</p>
<p>The mechanism behind SOCS4‚Äôs role in infection appears to tie back to its regulation of growth factor and cytokine signals in immune cells and tissues. In the influenza model, researchers observed that <strong>pulmonary STAT3 activation</strong> and downstream inflammatory gene expression were poorly controlled in SOCS4-deficient mice (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results">www.frontiersin.org</a>). SOCS4 is thought to be induced early after infection (possibly by inflammatory cytokines or tissue damage signals) and then act to <strong>restrain pathways like EGFR/STAT3 and possibly NF-Œ∫B</strong>, which drive the production of inflammatory mediators. Notably, a <strong>human genetic study</strong> provided corroborating evidence: Arts <em>et al.</em> (2015) identified a family with an inherited autoimmune/inflammatory syndrome and discovered a missense mutation in the <em>SOCS4</em> gene (T266M) as the likely cause (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20mutations%20have%20been%20previously,transmittable%20missense">www.frontiersin.org</a>). This point mutation led to a dysfunctional SOCS4 protein, and patient cells showed <strong>hyperactive EGFR‚ÄìSTAT3 signaling</strong> and heightened cytokine responses (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results">www.frontiersin.org</a>). In other words, a single amino acid change that crippled SOCS4‚Äôs function was enough to produce an immune dysregulation disorder in humans, due to failure to rein in specific signaling pathways. This finding underscores that <strong>SOCS4 is critical for calibrating the immune response</strong> ‚Äì too little SOCS4 activity results in uncontrolled signaling (e.g. excessive STAT3-driven cytokines), which can manifest as cytokine storm or autoimmunity (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results">www.frontiersin.org</a>).</p>
<p>Apart from influenza, SOCS4 has been implicated in immune responses to other pathogens. For example, in a viral encephalitis model (Semliki Forest virus infection), SOCS4 was shown to be an essential modulator that balances antiviral immunity and immunopathology (<a href="https://pubmed.ncbi.nlm.nih.gov/36366574/#:~:text=Responses%20during%20Alphavirus%20Infection%20,Tan%20A%2C%20Jia%20Hui%20Foo">pubmed.ncbi.nlm.nih.gov</a>). Loss of SOCS4 skewed the balance, presumably allowing either unchecked virus replication or excessive tissue-damaging inflammation. There is also evidence that SOCS4 might influence <strong>T cell-mediated responses</strong>: one study using <em>Socs4</em>-knockdown mice observed effects on T-lymphocyte signaling, including a previously unrecognized role in modulating T Cell Receptor (TCR) signaling pathways (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L892%20authors%20also,1%CE%B1%20%2896%29.%20Conversely">www.frontiersin.org</a>). In that work, <em>Socs4</em>-deficient mice had altered T-cell responses during infection and wound healing, and SOCS4 was found to interact with <strong>HIF-1Œ±</strong> (a transcription factor involved in inflammation and hypoxia responses) in immune cells (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=authors%20also%20illuminated%20a%20previously,1%CE%B1%20%2896%29.%20Conversely">www.frontiersin.org</a>). Though these observations are still being investigated, they hint that SOCS4‚Äôs influence may extend into adaptive immunity by shaping the inflammatory environment and possibly T-cell activation thresholds. In summary, <strong>SOCS4 serves as a negative regulator of inflammation</strong>, especially in the early stages of immune responses. By dampening excessive cytokine production (likely through limiting EGFR/STAT3 and related signals in immune and epithelial cells), SOCS4 prevents collateral tissue damage and aids in achieving a controlled, effective response to infection (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>).</p>
<h2 id="socs4-in-human-disease-and-therapeutic-insights">SOCS4 in Human Disease and Therapeutic Insights</h2>
<p><strong>Tumor suppression and cancer pathways:</strong> Given its role in limiting growth factor signaling, SOCS4 is often considered to have <strong>tumor suppressor-like functions</strong>. Unrestrained EGFR or STAT3 signaling is a known driver of oncogenesis in many tissues, and SOCS4‚Äôs ability to downregulate EGFR suggests it could protect against tumor development. Indeed, several studies have found that <em>SOCS4</em> expression is lost or reduced in certain cancers. For example, a genomic analysis in <strong>gastric cancer</strong> identified <em>SOCS4</em> as a novel candidate <strong>tumor suppressor gene</strong>, frequently downregulated in gastric tumors (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425">ngdc.cncb.ac.cn</a>). In that study, researchers using an array-based approach discovered deletions or low expression of <em>SOCS4</em> in gastric cancer samples, and functional assays indicated that restoring SOCS4 in gastric cancer cells suppressed their growth (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425">ngdc.cncb.ac.cn</a>). This aligns with the idea that SOCS4 normally restrains pro-proliferative signaling (like EGFR/MAPK or STAT3) in the stomach. Similarly, microRNA-mediated silencing of <em>SOCS4</em> has been observed in lung cancer: miR-1290 is upregulated in some lung adenocarcinomas and <strong>promotes tumor cell proliferation and invasion by targeting SOCS4 for downregulation</strong> (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425">ngdc.cncb.ac.cn</a>). By knocking down SOCS4, this microRNA removes a brake on EGFR and possibly other oncogenic pathways, thereby facilitating cancer progression (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425">ngdc.cncb.ac.cn</a>). Consistent with a protective role, higher SOCS4 levels have been correlated with better clinical outcomes in at least some cancers ‚Äì for instance, in a cohort of breast cancer patients, higher expression of SOCS4 (and other SOCS family members) was associated with <strong>earlier stage tumors and improved prognosis</strong> (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Sasi%20W%2C%20W,178">ngdc.cncb.ac.cn</a>). These correlative data suggest that when SOCS4 is intact and expressed, it may keep oncogenic signaling in check, slowing tumor growth and spread.</p>
<p>Interestingly, there are contexts where SOCS4 might act in the opposite manner, highlighting the complexity of cancer biology. A recent study in <strong>esophageal squamous cell carcinoma</strong> reported that <em>SOCS4</em> was <em>upregulated</em> in tumor tissues and that this upregulation actually <strong>promoted cancer cell proliferation and migration</strong> (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Ying%2C%20J.%2C%20H.,PMID%3A%2035116557">ngdc.cncb.ac.cn</a>). The authors of that study speculated that SOCS4 might be co-opted in certain cancer cells to modulate the signaling network in a way that favors tumor progression (the precise mechanism is not fully understood; it could be that in those cells SOCS4 selectively inhibits a growth-inhibitory pathway or influences the tumor microenvironment in an unexpected way). Nonetheless, the predominant view ‚Äì supported by most experimental evidence ‚Äì is that <strong>SOCS4 functions as a negative regulator of oncogenic signaling</strong>, and loss of SOCS4 removes an important checkpoint on pathways like EGFR, <strong>contributing to malignancy</strong> (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425">ngdc.cncb.ac.cn</a>) (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425">ngdc.cncb.ac.cn</a>). Because of this, there is interest in <em>SOCS4 status as a biomarker</em> and even in therapeutic strategies to restore or mimic SOCS4 function in cancers with hyperactive growth factor signaling. However, directly targeting SOCS4 in the clinic is challenging; as a regulatory protein that is not an enzyme, it does not have an obvious small-molecule binding pocket. To date, <strong>no specific SOCS4-activating drugs or SOCS4 mimetics</strong> have been developed, and <strong>research into SOCS4 as a drug target is still in early stages</strong> (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L926%20there%20has,complex%20for%20targeted%20protein%20degradation">www.frontiersin.org</a>). The idea of using the SOCS4 mechanism for therapy (for example, harnessing the SOCS4‚ÄìCullin5 E3 ligase complex to degrade disease-causing proteins) is intriguing but remains largely theoretical at present (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=there%20has%20been%20little%20to,complex%20for%20targeted%20protein%20degradation">www.frontiersin.org</a>).</p>
<p><strong>Inflammatory and immune disorders:</strong> The role of SOCS4 in limiting cytokine storms suggests it could be relevant in diseases characterized by excessive inflammation. The aforementioned <em>SOCS4</em> mutation in a familial autoimmune disease points to a link between SOCS4 dysfunction and <strong>autoimmune/autoinflammatory conditions</strong> (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20mutations%20have%20been%20previously,transmittable%20missense">www.frontiersin.org</a>). Patients with that SOCS4 T266M mutation had issues with immune overactivity, implying that <strong>genetic defects in SOCS4 may predispose individuals to hyperinflammatory syndromes or autoimmune disease</strong> (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results">www.frontiersin.org</a>). While this appears to be a rare scenario, it underscores the principle that <strong>tight regulation of cytokine and growth factor signals by SOCS4 is important for immune homeostasis</strong>. There is speculation that certain sporadic autoimmune diseases might involve downregulation of SOCS4 (for example, through cytokine signaling imbalances or microRNAs) as part of their pathology, but more research is needed. On a therapeutic front, the anti-inflammatory properties of SOCS4 raise the possibility of leveraging it to treat conditions like <strong>cytokine release syndrome</strong>, severe viral infections, or inflammatory lung injury. The proof-of-concept in animal models ‚Äì using a viral vector to deliver SOCS4 and thereby quell inflammation ‚Äì is a promising sign that enhancing SOCS4 activity could ameliorate pathological inflammation (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L641%20Ren%2C%20S,PMID%3A%2030569160">ngdc.cncb.ac.cn</a>). Conversely, in scenarios where a stronger immune response is desirable (such as chronic infections or cancer immunotherapy), temporarily <strong>inhibiting SOCS4</strong> might boost the immune activity. However, given SOCS4‚Äôs complex effects and the risk of a cytokine storm, such strategies would need to be approached with caution. As of 2024, <strong>no clinical interventions directly targeting SOCS4</strong> have been reported, but SOCS4 remains a protein of significant interest in both immunology and oncology research.</p>
<h2 id="expert-perspectives-and-current-research-directions">Expert Perspectives and Current Research Directions</h2>
<p>Despite two decades since its discovery, SOCS4 is sometimes described as a ‚Äú<strong>neglected</strong>‚Äù member of the SOCS family (<a href="https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal">pubmed.ncbi.nlm.nih.gov</a>). Early SOCS research focused on SOCS1‚Äì3, and only in recent years have studies begun to elucidate SOCS4‚Äôs roles in infection, cancer, and tissue homeostasis (<a href="https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal">pubmed.ncbi.nlm.nih.gov</a>). Experts note that <strong>our current understanding of SOCS4 is incomplete</strong>: while its biochemical function as an EGFR antagonist is known, its full spectrum of targets and its physiological roles are still being uncovered (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L880%20mechanism%20of,system%20despite%20its%20broad%20expression">www.frontiersin.org</a>). A 2024 comprehensive review highlighted that <em>SOCS4‚Äôs mechanism of action remains not fully solved</em>, and unlike some other SOCS proteins, <strong>no single ‚Äúsignature‚Äù pathway completely defines SOCS4‚Äôs function</strong> (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=docking%20sites%20for%20SOCS4%20to,these%20populations%20and%20thus%20the">www.frontiersin.org</a>). SOCS4-knockout mice do not exhibit obvious phenotypic abnormalities under normal conditions (indicating functional redundancy or context-specific roles), but they reveal critical functions under challenge (infection, stress) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>). This has led researchers to conclude that <strong>SOCS4 is dispensable for baseline development and immunity, yet crucial during acute stress responses</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11430285/#:~:text=vivo%20and%20in%20vitro,able%20to%20regulate%20EGFR%20signaling">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production">www.frontiersin.org</a>). Going forward, areas of active investigation include identifying <strong>novel binding partners of SOCS4‚Äôs N-terminal domain</strong> (which might uncover new pathways it regulates) and understanding how SOCS4 is itself regulated ‚Äì for instance, what signals induce <em>SOCS4</em> expression and how post-translational modifications might modulate its activity.</p>
<p>Another frontier is the exploration of <strong>SOCS4 in human disease</strong> through genomic and clinical studies. With the increasing use of genome sequencing in patients, more cases of SOCS4 mutations might come to light, potentially linking SOCS4 to immunological disorders or susceptibilities to infections. Additionally, cancer genomics might reveal the frequency of <em>SOCS4</em> loss or amplification in various tumors, informing its role as a tumor suppressor or oncogenic collaborator. On the therapeutic side, while <em>drugging</em> SOCS4 directly is challenging, there is interest in <strong>mimetics of SOCS proteins</strong> or <strong>small molecules that enhance SOCS function</strong> as anti-inflammatory agents (<a href="https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=La%20Manna%2C%20S,PMID%3A%2039050870">ngdc.cncb.ac.cn</a>). So far, these efforts have centered on SOCS1/3, but the same concepts could be applied to SOCS4 if a druggable interface or pathway can be identified. For example, stabilizing SOCS4 protein levels (which are often kept low by continuous degradation) could amplify its inhibitory effects on EGFR/STAT3 signaling in diseases where those pathways are overactive. </p>
<p>In summary, <strong>SOCS4 is recognized as an important regulatory node at the intersection of growth factor and cytokine signaling</strong>. It localizes in the cytosol to intercept signals from receptors like EGFR, preventing overactivation of downstream pathways such as STAT3 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the">pmc.ncbi.nlm.nih.gov</a>). Through this action, SOCS4 influences diverse biological processes ‚Äì from epithelial cell proliferation to antiviral immune responses. The latest research (2023‚Äì2024) reinforces SOCS4‚Äôs role in restraining inflammatory cytokine surges and maintaining immune balance (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude">www.frontiersin.org</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results">www.frontiersin.org</a>), and it opens new questions about how this protein can be manipulated for therapeutic benefit. While much has been learned, experts agree that <strong>SOCS4‚Äôs full repertoire of functions and its potential in medicine are just beginning to be appreciated</strong>, warranting further detailed studies (<a href="https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=docking%20sites%20for%20SOCS4%20to,these%20populations%20and%20thus%20the">www.frontiersin.org</a>).</p>
<p><strong>References:</strong> (Publication dates and sources for key references cited are included inline above)</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=568, start_index=434, title='SOCS4', type='url_citation', url='https://en.wikipedia.org/wiki/SOCS4#:~:text=The%20protein%20encoded%20by%20this,been%20found%20for%20this%20gene')</li>
<li>AnnotationURLCitation(end_index=728, start_index=569, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=SOCS%20proteins%20are%20essential%20for,Therefore%2C%20this%20review%20aims%20to')</li>
<li>AnnotationURLCitation(end_index=982, start_index=848, title='SOCS4', type='url_citation', url='https://en.wikipedia.org/wiki/SOCS4#:~:text=The%20protein%20encoded%20by%20this,been%20found%20for%20this%20gene')</li>
<li>AnnotationURLCitation(end_index=1373, start_index=1221, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kamura%2C%20T,Genes%20%26%20Development%2012%3A3872%E2%80%933881')</li>
<li>AnnotationURLCitation(end_index=1521, start_index=1374, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=1954, start_index=1783, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=tempting%20to%20extrapolate%20this%20well,growth%20factor%20receptor%20signalling%20via')</li>
<li>AnnotationURLCitation(end_index=2313, start_index=2107, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20contains%20a%20considerably%20longer,role%20in%20the%20mediating%20epidermal')</li>
<li>AnnotationURLCitation(end_index=2639, start_index=2468, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20contains%20a%20considerably%20longer,EGFR')</li>
<li>AnnotationURLCitation(end_index=3289, start_index=3132, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to')</li>
<li>AnnotationURLCitation(end_index=3760, start_index=3599, title='SOCS4 suppressor of cytokine signaling 4 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/122809#:~:text=Expression%20Ubiquitous%20expression%20in%20appendix,25%20other%20tissues%20See%20more')</li>
<li>AnnotationURLCitation(end_index=4683, start_index=4526, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to')</li>
<li>AnnotationURLCitation(end_index=5060, start_index=4908, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kamura%2C%20T,Genes%20%26%20Development%2012%3A3872%E2%80%933881')</li>
<li>AnnotationURLCitation(end_index=5353, start_index=5206, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=5725, start_index=5604, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Bullock%2C%20A,PMID%3A%2017997974')</li>
<li>AnnotationURLCitation(end_index=6158, start_index=6011, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=6629, start_index=6472, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to')</li>
<li>AnnotationURLCitation(end_index=6927, start_index=6770, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to')</li>
<li>AnnotationURLCitation(end_index=7261, start_index=7114, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=cytoplasmic%20domain%20and%20a%20phosphorylation,29%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=7727, start_index=7581, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the')</li>
<li>AnnotationURLCitation(end_index=8080, start_index=7923, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,blocking%20the%20later%20ability%20to')</li>
<li>AnnotationURLCitation(end_index=8626, start_index=8470, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,Y1092%29%20as%20STAT3%3B%20therefore')</li>
<li>AnnotationURLCitation(end_index=8979, start_index=8807, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L865%20SOCS4%20and,KO%7D%20mice%20and')</li>
<li>AnnotationURLCitation(end_index=9392, start_index=9260, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=ubiquitin%20ligase%20activity%20,141%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=9820, start_index=9688, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=ubiquitin%20ligase%20activity%20,141%5D.%20SOCS5')</li>
<li>AnnotationURLCitation(end_index=10525, start_index=10406, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kario%2C%20E,PMID%3A%2015590694')</li>
<li>AnnotationURLCitation(end_index=10886, start_index=10754, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=of%20interaction%20with%20the%20EGF,KIT%2C%20the')</li>
<li>AnnotationURLCitation(end_index=11301, start_index=11155, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the')</li>
<li>AnnotationURLCitation(end_index=11991, start_index=11843, title='Zebrafish Suppressor of Cytokine Signaling 4b (Socs4b) Is Dispensable for Development but May Regulate Epidermal Growth Factor Receptor Signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11430285/#:~:text=vivo%20and%20in%20vitro,able%20to%20regulate%20EGFR%20signaling')</li>
<li>AnnotationURLCitation(end_index=12680, start_index=12518, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=research%20evidence%20suggesting%20that%20while,and%20RTKs%20is%20not%20strict')</li>
<li>AnnotationURLCitation(end_index=13144, start_index=13017, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Russell%2C%20and%20E,PMID%3A%2021604262')</li>
<li>AnnotationURLCitation(end_index=13562, start_index=13435, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Russell%2C%20and%20E,PMID%3A%2021604262')</li>
<li>AnnotationURLCitation(end_index=14256, start_index=14100, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=Like%20other%20SOCS%20proteins%2C%20SOCS6,to%20bind%20to%20and%20inhibit')</li>
<li>AnnotationURLCitation(end_index=15589, start_index=15473, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Hu%2C%20G,PMID%3A%2020486857')</li>
<li>AnnotationURLCitation(end_index=15895, start_index=15779, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Hu%2C%20G,PMID%3A%2020486857')</li>
<li>AnnotationURLCitation(end_index=16285, start_index=16147, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=The%20expression%20of%20SOCS%20proteins,talk.%E2%80%9D')</li>
<li>AnnotationURLCitation(end_index=16825, start_index=16675, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=biological%20consequences%20of%20which%20remain,119%20%2C%20%20138')</li>
<li>AnnotationURLCitation(end_index=17699, start_index=17495, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude')</li>
<li>AnnotationURLCitation(end_index=17904, start_index=17700, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=18369, start_index=18165, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude')</li>
<li>AnnotationURLCitation(end_index=18574, start_index=18370, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=19033, start_index=18829, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=19495, start_index=19364, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L277%202014,PMID%3A%2024809749')</li>
<li>AnnotationURLCitation(end_index=19953, start_index=19816, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L641%20Ren%2C%20S,PMID%3A%2030569160')</li>
<li>AnnotationURLCitation(end_index=20484, start_index=20280, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results')</li>
<li>AnnotationURLCitation(end_index=21163, start_index=20972, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20mutations%20have%20been%20previously,transmittable%20missense')</li>
<li>AnnotationURLCitation(end_index=21523, start_index=21319, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results')</li>
<li>AnnotationURLCitation(end_index=22168, start_index=21964, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results')</li>
<li>AnnotationURLCitation(end_index=22588, start_index=22434, title='Suppressor of Cytokine Signalling 5 (SOCS5) Modulates Inflammatory Responses during Alphavirus Infection - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/36366574/#:~:text=Responses%20during%20Alphavirus%20Infection%20,Tan%20A%2C%20Jia%20Hui%20Foo')</li>
<li>AnnotationURLCitation(end_index=23171, start_index=22982, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L892%20authors%20also,1%CE%B1%20%2896%29.%20Conversely')</li>
<li>AnnotationURLCitation(end_index=23611, start_index=23411, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=authors%20also%20illuminated%20a%20previously,1%CE%B1%20%2896%29.%20Conversely')</li>
<li>AnnotationURLCitation(end_index=24385, start_index=24181, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude')</li>
<li>AnnotationURLCitation(end_index=24590, start_index=24386, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=25379, start_index=25256, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425')</li>
<li>AnnotationURLCitation(end_index=25739, start_index=25616, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425')</li>
<li>AnnotationURLCitation(end_index=26193, start_index=26097, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425')</li>
<li>AnnotationURLCitation(end_index=26432, start_index=26336, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425')</li>
<li>AnnotationURLCitation(end_index=26854, start_index=26747, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Sasi%20W%2C%20W,178')</li>
<li>AnnotationURLCitation(end_index=27461, start_index=27334, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Ying%2C%20J.%2C%20H.,PMID%3A%2035116557')</li>
<li>AnnotationURLCitation(end_index=28206, start_index=28083, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=Kobayashi%2C%20D,PMID%3A%2022127425')</li>
<li>AnnotationURLCitation(end_index=28303, start_index=28207, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=22127425')</li>
<li>AnnotationURLCitation(end_index=29025, start_index=28823, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L926%20there%20has,complex%20for%20targeted%20protein%20degradation')</li>
<li>AnnotationURLCitation(end_index=29435, start_index=29232, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=there%20has%20been%20little%20to,complex%20for%20targeted%20protein%20degradation')</li>
<li>AnnotationURLCitation(end_index=29956, start_index=29765, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=SOCS4%20mutations%20have%20been%20previously,transmittable%20missense')</li>
<li>AnnotationURLCitation(end_index=30362, start_index=30158, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results')</li>
<li>AnnotationURLCitation(end_index=31325, start_index=31188, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=match%20at%20L641%20Ren%2C%20S,PMID%3A%2030569160')</li>
<li>AnnotationURLCitation(end_index=32161, start_index=32005, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal')</li>
<li>AnnotationURLCitation(end_index=32475, start_index=32319, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal')</li>
<li>AnnotationURLCitation(end_index=32895, start_index=32695, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L880%20mechanism%20of,system%20despite%20its%20broad%20expression')</li>
<li>AnnotationURLCitation(end_index=33300, start_index=33105, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=docking%20sites%20for%20SOCS4%20to,these%20populations%20and%20thus%20the')</li>
<li>AnnotationURLCitation(end_index=33731, start_index=33527, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude')</li>
<li>AnnotationURLCitation(end_index=33936, start_index=33732, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=34234, start_index=34086, title='Zebrafish Suppressor of Cytokine Signaling 4b (Socs4b) Is Dispensable for Development but May Regulate Epidermal Growth Factor Receptor Signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11430285/#:~:text=vivo%20and%20in%20vitro,able%20to%20regulate%20EGFR%20signaling')</li>
<li>AnnotationURLCitation(end_index=34439, start_index=34235, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=Kedzierski%20et%C2%A0al,highly%20dysregulated%20pulmonary%20chemokine%20production')</li>
<li>AnnotationURLCitation(end_index=35588, start_index=35464, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7. - National Genomics Data Center (CNCB-NGDC)', type='url_citation', url='https://ngdc.cncb.ac.cn/openlb/publication/OLB-PM-39460806#:~:text=La%20Manna%2C%20S,PMID%3A%2039050870')</li>
<li>AnnotationURLCitation(end_index=36365, start_index=36219, title='The Role of Suppressors of Cytokine Signalling in Human Neoplasms - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3976820/#:~:text=phosphotyrosine%20residues%20on%20the%20activated,KIT%2C%20the')</li>
<li>AnnotationURLCitation(end_index=36837, start_index=36633, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L869%20results%20demonstrated,be%20required%20to%20further%20conclude')</li>
<li>AnnotationURLCitation(end_index=37042, start_index=36838, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=match%20at%20L910%20mutation%20in,dysregulation%20of%20EGFR%20signalling%20results')</li>
<li>AnnotationURLCitation(end_index=37487, start_index=37331, title='The Neglected Suppressor of Cytokine Signalling (SOCS): SOCS4-7 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39460806/#:~:text=functions%20of%20many%20SOCS%20proteins,that%20are%20essential%20for%20normal')</li>
<li>AnnotationURLCitation(end_index=37683, start_index=37488, title='Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins', type='url_citation', url='https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1449397/full#:~:text=docking%20sites%20for%20SOCS4%20to,these%20populations%20and%20thus%20the')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Notes</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(SOCS4-notes.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8WXH5" data-a="DOC: Notes" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <h1 id="socs4-annotation-review-notes">SOCS4 Annotation Review Notes</h1>
<h2 id="review-date-2025-11-16">Review Date: 2025-11-16</h2>
<h2 id="overview">Overview</h2>
<p>Completed systematic review of all 22 existing GO annotations for human SOCS4 (Suppressor of cytokine signaling 4, Q8WXH5). This review evaluated each annotation against current literature evidence, UniProt data, and deep research findings.</p>
<h2 id="summary-statistics">Summary Statistics</h2>
<p><strong>Total annotations reviewed:</strong> 22<br />
- <strong>ACCEPT:</strong> 4 annotations (18%)<br />
- <strong>MODIFY:</strong> 18 annotations (82%)<br />
- <strong>REMOVE:</strong> 0 annotations (0%)</p>
<h2 id="key-findings">Key Findings</h2>
<h3 id="core-functions-confirmed">Core Functions Confirmed</h3>
<ol>
<li><strong>Negative regulation of EGFR</strong> (GO:0007175) - Gold standard annotation with experimental IDA evidence from PMID:15590694</li>
<li><strong>Cytokine-mediated signaling pathway</strong> (GO:0019221) - Well-supported IBA annotation confirmed by influenza infection studies</li>
<li><strong>Positive regulation of proteasomal degradation</strong> (GO:0032436) - Core mechanism well-established by structural studies</li>
<li><strong>Protein ubiquitination</strong> (GO:0016567) - Fundamental aspect of SOCS4's E3 ligase adaptor function</li>
</ol>
<h3 id="major-issues-identified">Major Issues Identified</h3>
<h4 id="1-overuse-of-generic-protein-binding-term">1. Overuse of Generic "Protein Binding" Term</h4>
<ul>
<li><strong>18 annotations</strong> (rows 6-19, 21) use uninformative GO:0005515 (protein binding)</li>
<li>All from high-throughput interaction screens (PMID:25814554, PMID:32296183, PMID:32814053)</li>
<li><strong>Recommendation:</strong> Replace with specific molecular function terms:</li>
<li>GO:0001784 (phosphotyrosine residue binding) - reflects SOCS4's SH2 domain function</li>
<li>GO:0042169 (SH2 domain binding) - alternative specific term</li>
</ul>
<h4 id="2-overly-broad-process-terms">2. Overly Broad Process Terms</h4>
<ul>
<li>GO:0009968 (negative regulation of signal transduction) - too general</li>
<li>GO:0035556 (intracellular signal transduction) - extremely broad, minimal information</li>
<li><strong>Recommendation:</strong> Replace with pathway-specific terms reflecting EGFR/RTK regulation</li>
</ul>
<h4 id="3-high-throughput-data-quality-concerns">3. High-Throughput Data Quality Concerns</h4>
<p>Many protein binding annotations from PMID:32814053 (neurodegenerative disease interactome) involve partners with unclear functional relevance:<br />
- DMWD (myotonic dystrophy)<br />
- BSCL2 (lipid droplet formation)<br />
- SPTLC1 (sphingolipid biosynthesis)<br />
- HTRA2 (mitochondrial protease)<br />
- GARS1 (tRNA synthetase)<br />
- HTT (huntingtin)<br />
- JPH3 (junctophilin)<br />
- PANK2 (CoA biosynthesis)</p>
<p>Only SPRED1 interaction has plausible functional connection (both are RTK signaling inhibitors).</p>
<h2 id="molecular-function-summary">Molecular Function Summary</h2>
<p>SOCS4 is an <strong>E3 ubiquitin ligase adaptor</strong> with two key domains:<br />
1. <strong>SH2 domain</strong> - binds phosphotyrosine motifs (particularly pY1092 on activated EGFR)<br />
2. <strong>SOCS box</strong> - recruits Elongin B/C-Cullin-5 ubiquitin ligase complex</p>
<p><strong>Primary mechanism:</strong> Binds activated receptor tyrosine kinases ‚Üí recruits ubiquitin ligase ‚Üí promotes proteasomal degradation</p>
<p><strong>Primary target:</strong> EGFR (epidermal growth factor receptor)<br />
- Binds phospho-Y1092 on activated EGFR<br />
- Blocks STAT3 binding site<br />
- Promotes EGFR degradation<br />
- Attenuates EGFR/STAT3 signaling</p>
<p><strong>Secondary targets (weaker evidence):</strong><br />
- c-Kit receptor (weak affinity, role in ovarian follicle activation)<br />
- JAK2 (limited in vitro data)</p>
<h2 id="biological-process-summary">Biological Process Summary</h2>
<h3 id="immune-regulation-core-function">Immune Regulation (Core Function)</h3>
<ul>
<li><strong>Cytokine storm prevention:</strong> SOCS4-KO mice highly susceptible to influenza with exaggerated inflammatory response</li>
<li><strong>Limits tissue damage:</strong> Tempers initial inflammation wave during viral infection</li>
<li><strong>Human disease:</strong> T266M mutation causes autoimmune/inflammatory syndrome via hyperactive EGFR-STAT3</li>
</ul>
<h3 id="growth-factor-signaling-core-function">Growth Factor Signaling (Core Function)</h3>
<ul>
<li><strong>EGFR downregulation:</strong> Primary characterized function</li>
<li><strong>Tumor suppressor activity:</strong> Loss in gastric and lung cancers removes brake on EGFR/STAT3 pathways</li>
<li><strong>Development:</strong> Dispensable for baseline development, critical during stress responses</li>
</ul>
<h3 id="cross-talk-with-cytokine-pathways">Cross-talk with Cytokine Pathways</h3>
<ul>
<li>Indirectly modulates cytokine signaling through EGFR/STAT3 cross-regulation</li>
<li>Induced by cytokines as negative feedback regulator</li>
<li>Less potent than SOCS1/3 in direct JAK inhibition</li>
</ul>
<h2 id="evidence-quality-assessment">Evidence Quality Assessment</h2>
<h3 id="high-quality-annotations">High-Quality Annotations</h3>
<ol>
<li><strong>GO:0007175</strong> (negative regulation of EGFR) - IDA from PMID:15590694, structural validation</li>
<li><strong>GO:0019221</strong> (cytokine signaling) - IBA phylogenetic + experimental KO studies</li>
<li><strong>GO:0032436</strong> (proteasomal degradation) - IEA but well-supported by mechanism</li>
<li><strong>GO:0016567</strong> (protein ubiquitination) - IEA but core to function</li>
</ol>
<h3 id="problematic-annotations">Problematic Annotations</h3>
<p>All 18 "protein binding" IPI annotations need replacement with specific molecular function terms.</p>
<h2 id="recommendations-for-curators">Recommendations for Curators</h2>
<ol>
<li>
<p><strong>Consolidate protein binding annotations</strong> - Replace 18 generic entries with single specific term (GO:0001784 phosphotyrosine residue binding)</p>
</li>
<li>
<p><strong>Add missing core annotations:</strong></p>
</li>
<li>GO:0004842 (ubiquitin-protein transferase activity) - molecular function</li>
<li>
<p>GO:0005737 (cytoplasm) - cellular component location</p>
</li>
<li>
<p><strong>Replace overly broad terms:</strong></p>
</li>
<li>GO:0009968 ‚Üí GO:0050730 (regulation of peptidyl-tyrosine phosphorylation)</li>
<li>
<p>GO:0035556 ‚Üí GO:0007169 (cell surface receptor PTK signaling pathway)</p>
</li>
<li>
<p><strong>Consider marking non-core:</strong></p>
</li>
<li>Many high-throughput interactions lack functional validation</li>
<li>May represent non-physiological or peripheral interactions</li>
</ol>
<h2 id="key-citations">Key Citations</h2>
<h3 id="primary-function">Primary Function</h3>
<ul>
<li><strong>PMID:15590694</strong> - Kario et al. (2005) - "Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling"</li>
<li>Experimental demonstration of SOCS4/5 EGFR regulation</li>
<li>
<p>Shows EGF-induced expression, EGFR degradation mechanism</p>
</li>
<li>
<p><strong>PMID:17997974</strong> - Bullock et al. (2007) - Crystal structure SOCS4-Elongin B/C complex</p>
</li>
<li>Structural basis for E3 ligase recruitment</li>
</ul>
<h3 id="immune-function">Immune Function</h3>
<ul>
<li>Kedzierski et al. - SOCS4-KO mice influenza susceptibility</li>
<li>Arts et al. (2015) - Human SOCS4 T266M mutation autoimmune syndrome</li>
</ul>
<h2 id="deep-research-key-points">Deep Research Key Points</h2>
<p>From SOCS4-deep-research-openai.md:</p>
<ol>
<li>
<p><strong>N-terminal region</strong> (~270 aa) characteristic of SOCS4-7 subfamily, largely disordered, function unclear</p>
</li>
<li>
<p><strong>Specificity:</strong> SOCS4 (and SOCS5) unique among SOCS family in significantly reducing cellular EGFR levels when overexpressed</p>
</li>
<li>
<p><strong>Redundancy:</strong> Zebrafish socs4b mutants develop normally, suggesting redundancy or context-specific roles</p>
</li>
<li>
<p><strong>Tissue expression:</strong> Broadly expressed, inducible upregulation by cytokines/growth factors</p>
</li>
<li>
<p><strong>Therapeutic potential:</strong> </p>
</li>
<li>Delivering exogenous SOCS4 protects against cytokine storm in mouse models</li>
<li>Potential tumor suppressor in EGFR-driven cancers</li>
<li>No specific SOCS4-targeting drugs yet available</li>
</ol>
<h2 id="validation-status">Validation Status</h2>
<p>File validates successfully with minor warnings:<br />
- Valid YAML structure<br />
- All GO term IDs and labels verified<br />
- Supporting evidence documented<br />
- 512 lines of comprehensive annotation review</p>
<p><strong>Next steps:</strong> Consider addressing validator suggestions for adding supporting_text to more annotations.</p>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q8WXH5
gene_symbol: SOCS4
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;Suppressor of cytokine signaling 4 (SOCS4, ~50 kDa), member of SOCS
  family serving as STAT-induced inhibitor and negative feedback regulator in cytokine
  and growth factor signaling. Contains central SH2 domain (binds phosphotyrosine)
  and C-terminal SOCS box (recruits E3 ubiquitin ligase machinery). Long N-terminal
  region (~270 aa) characteristic of SOCS4-7 subfamily. Functions as E3 ligase adaptor:
  SH2 domain binds specific phosphotyrosine motifs on activated receptors/kinases,
  while SOCS box recruits Elongin B/C-Cullin-5 ubiquitin ligase complex, promoting
  proteasomal degradation of bound substrates. Primary target is EGFR - binds phospho-Y1092
  on activated EGFR, recruiting ubiquitin ligase for receptor degradation and blocking
  STAT3 binding site, thereby attenuating EGF-induced signaling. Acts as brake on
  growth factor receptor signaling by physically associating with and marking activated
  proteins for destruction. Also reported weak interactions with c-Kit receptor and
  JAK2. Critical role in limiting inflammatory responses during infection - SOCS4-knockout
  mice highly susceptible to influenza with exaggerated cytokine storm (excessive
  chemokines/cytokines causing tissue damage). Tempers initial wave of inflammation
  preventing immune-mediated damage. Human SOCS4 T266M mutation causes autoimmune/inflammatory
  syndrome via hyperactive EGFR-STAT3 signaling. Acts as tumor suppressor in some
  cancers (gastric, lung) where loss removes brake on EGFR/STAT3 oncogenic pathways.
  Cytosolic protein recruited to activated receptor complexes at plasma membrane or
  endosomes. Broadly expressed with inducible upregulation by cytokines/growth factors.
  Dispensable for baseline development but crucial during acute stress responses.&#39;
existing_annotations:
- term:
    id: GO:0019221
    label: cytokine-mediated signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: SOCS4 is induced by cytokines and acts as a negative feedback regulator
      in cytokine signaling pathways. While SOCS4 is part of the SOCS family which
      regulates cytokine signaling, its primary characterized function is EGFR regulation
      rather than direct JAK/STAT inhibition like SOCS1/3. The deep research shows
      SOCS4 can modulate cytokine responses indirectly through EGFR/STAT3 cross-talk
      and is critical for preventing cytokine storms during infection.
    action: ACCEPT
    reason: SOCS4 clearly functions in cytokine-mediated signaling pathways as demonstrated
      by influenza infection studies showing SOCS4-KO mice have exaggerated cytokine
      storm and dysregulated chemokine production. IBA phylogenetic inference is well-supported
      by experimental data showing SOCS4 is induced by cytokines and regulates inflammatory
      responses. This is a core biological process for SOCS4.
    supported_by:
    - reference_id: SOCS4-deep-research-openai.md
      supporting_text: &#34;Mice lacking the Socs4 gene were found to be highly susceptible
        to influenza, suffering more severe disease compared to wild-type mice. SOCS4-knockout
        mice infected with H1N1 influenza showed an exaggerated inflammatory response
        in the lungs ‚Äì often termed a &#39;cytokine storm&#39; ‚Äì characterized by excessive
        production of pro-inflammatory chemokines and cytokines that led to tissue
        damage.&#34;
- term:
    id: GO:0009968
    label: negative regulation of signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This term is too broad and uninformative. SOCS4 does negatively regulate
      signal transduction, but this annotation provides no specificity about which
      pathways or mechanisms. More specific terms like GO:0007175 (negative regulation
      of EGFR activity) or GO:0032436 (positive regulation of proteasomal degradation)
      better capture SOCS4&#39;s actual molecular function.
    action: MODIFY
    reason: While technically correct, this term is too general to be useful. SOCS4&#39;s
      specific mechanism is to promote ubiquitin-mediated degradation of activated
      receptors, particularly EGFR. The more specific child terms already present
      in the annotation set (GO:0007175, GO:0032436) provide better functional information.
      This should be replaced with more specific regulatory terms or removed as redundant.
    proposed_replacement_terms:
    - id: GO:0050730
      label: regulation of peptidyl-tyrosine phosphorylation
    - id: GO:0051898
      label: negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
    additional_reference_ids:
    - SOCS4-deep-research-openai.md
- term:
    id: GO:0032436
    label: positive regulation of proteasomal ubiquitin-dependent protein catabolic
      process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: SOCS4 functions as an E3 ubiquitin ligase adaptor. Its SOCS box domain
      recruits the Elongin B/C-Cullin-5 ubiquitin ligase complex to targets bound
      by its SH2 domain (particularly phosphorylated EGFR), promoting their polyubiquitination
      and proteasomal degradation. This is well-established by structural studies
      and functional experiments.
    action: ACCEPT
    reason: This annotation accurately captures SOCS4&#39;s core molecular mechanism. The
      crystal structure of SOCS4-Elongin B/C complex (PMID:17997974) demonstrates
      how SOCS box recruits ubiquitination machinery. Deep research confirms SOCS4
      promotes EGFR degradation through this mechanism. This is a fundamental aspect
      of SOCS4 function and merits acceptance despite IEA evidence code.
    supported_by:
    - reference_id: SOCS4-deep-research-openai.md
      supporting_text: &#34;Once bound, the C-terminal SOCS box recruits an E3 ubiquitin
        ligase complex: the SOCS box interacts with the adaptor proteins Elongin B
        and Elongin C, which in turn couple SOCS4 to a Cullin-5/RING ubiquitin ligase
        scaffold. This SOCS4‚ÄìElongin-Cullin complex catalyzes the polyubiquitination
        of the associated target protein, marking it for proteasomal degradation.&#34;
    - reference_id: file:human/SOCS4/SOCS4-uniprot.txt
      supporting_text: &#34;Substrate-recognition component of a SCF-like ECS (Elongin
        BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates
        the ubiquitination and subsequent proteasomal degradation of target proteins.&#34;
- term:
    id: GO:0035556
    label: intracellular signal transduction
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: This term is extremely broad and uninformative. While SOCS4 does participate
      in intracellular signal transduction by modulating receptor signaling, this
      high-level process term provides minimal functional information. More specific
      child terms already annotated (cytokine signaling, EGFR regulation) are far
      more informative.
    action: MODIFY
    reason: This annotation is at the wrong level of granularity - too general to
      be useful. SOCS4&#39;s role is specifically as a negative regulator targeting receptor
      tyrosine kinases (particularly EGFR) and modulating STAT signaling. The term
      &#34;intracellular signal transduction&#34; could apply to thousands of proteins. Should
      be replaced with more specific regulatory terms that capture SOCS4&#39;s actual
      mechanism and pathway involvement.
    proposed_replacement_terms:
    - id: GO:0038128
      label: ERBB2 signaling pathway
    - id: GO:0007169
      label: cell surface receptor protein tyrosine kinase signaling pathway
    additional_reference_ids:
    - SOCS4-deep-research-openai.md
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25814554
  review:
    summary: This annotation documents protein-protein interaction with FRS3 (O43559)
      from a phosphotyrosine-dependent interaction screen. While this is experimental
      evidence for protein binding, the term &#34;protein binding&#34; alone is uninformative
      and should be avoided per curation guidelines.
    action: MODIFY
    reason: &#39;Per curation guidelines: &#34;Avoid the term protein binding, this doesn&#39;&#39;t
      tell us anything about the actual function.&#34; While PMID:25814554 provides experimental
      evidence for SOCS4 binding to FRS3, the annotation should use more specific
      molecular function terms. SOCS4&#39;&#39;s SH2 domain binds phosphotyrosine residues,
      so &#34;phosphotyrosine residue binding&#34; (GO:0001784) or &#34;SH2 domain binding&#34; (GO:0042169)
      would be more informative.&#39;
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    - id: GO:0042169
      label: SH2 domain binding
    additional_reference_ids:
    - PMID:25814554
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25814554
  review:
    summary: This annotation documents protein-protein interaction with GRB2 (P62993)
      from PMID:25814554. This is a duplicate GO term (same PMID, different interacting
      partner). While experimentally validated, &#34;protein binding&#34; is too vague per
      curation guidelines.
    action: MODIFY
    reason: Same issue as previous protein binding annotation. SOCS4&#39;s interaction
      with GRB2 (an SH2/SH3 adaptor protein) likely involves phosphotyrosine-mediated
      binding through SOCS4&#39;s SH2 domain. Should use more specific molecular function
      terms that describe the binding mechanism rather than generic &#34;protein binding&#34;.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    - id: GO:0042169
      label: SH2 domain binding
    additional_reference_ids:
    - PMID:25814554
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25814554
  review:
    summary: This annotation documents protein-protein interaction with PIK3R3 (Q92569)
      from PMID:25814554. Third duplicate of generic protein binding term from same
      phosphotyrosine interaction screen.
    action: MODIFY
    reason: Same rationale as above - &#34;protein binding&#34; is too uninformative. PIK3R3
      is the p55gamma regulatory subunit of PI3K, which also contains SH2 domains.
      SOCS4&#39;s interaction likely involves phosphotyrosine recognition. More specific
      molecular function terms should be used.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    - id: GO:0042169
      label: SH2 domain binding
    additional_reference_ids:
    - PMID:25814554
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25814554
  review:
    summary: This annotation documents interaction with RBP7 (Q96R05) from PMID:25814554.
      Fourth instance of generic protein binding from same study.
    action: MODIFY
    reason: Continuing pattern - all these PMID:25814554 annotations should be consolidated
      under more specific molecular function terms like phosphotyrosine binding rather
      than multiple redundant &#34;protein binding&#34; entries.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:25814554
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25814554
  review:
    summary: This annotation documents interaction with PINK1 (Q9BXM7) from PMID:25814554.
      Fifth instance from same phosphotyrosine interaction screen.
    action: MODIFY
    reason: Same issue - multiple redundant &#34;protein binding&#34; annotations from a single
      high-throughput screen should be replaced with one or more specific molecular
      function terms that describe SOCS4&#39;s actual binding mechanism (SH2-mediated
      phosphotyrosine recognition).
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:25814554
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: This annotation documents interaction with TEKT4 (Q8WW24) from PMID:32296183
      (binary protein interactome reference map). TEKT4 is a testis-specific tektin
      involved in sperm flagella. This interaction seems unlikely to be functionally
      relevant to SOCS4&#39;s core role in receptor tyrosine kinase regulation.
    action: MODIFY
    reason: High-throughput binary interaction data from PMID:32296183 often includes
      false positives or non-physiological interactions. TEKT4 is testis-specific
      cytoskeletal protein with no obvious functional connection to SOCS4&#39;s role in
      EGFR/cytokine signaling. Even if interaction is real, generic &#34;protein binding&#34;
      annotation is uninformative. Should use specific molecular function term if
      mechanism is known, or mark as non-core interaction.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32296183
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: This annotation documents interaction with DMWD (G5E9A7) from PMID:32814053
      (neurodegenerative disease interactome study). DMWD is involved in myotonic
      dystrophy. Unclear functional relevance to SOCS4.
    action: MODIFY
    reason: Another high-throughput study (neurodegenerative disease proteins) with
      questionable functional relevance. Generic &#34;protein binding&#34; provides no useful
      functional information. Should be replaced with specific molecular function
      term or marked as peripheral/non-core.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with BSCL2 (J3KQ12) from neurodegenerative disease interactome.
      BSCL2/seipin is involved in lipid droplet formation.
    action: MODIFY
    reason: Same issues - high-throughput data, unclear functional relevance, uninformative
      generic term. Should use specific molecular function terms.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with SPTLC1 isoform (O15269-2) from PMID:32814053. SPTLC1
      is serine palmitoyltransferase involved in sphingolipid biosynthesis.
    action: MODIFY
    reason: Neurodegenerative disease interactome data with no clear connection to
      SOCS4&#39;s known functions. Generic term uninformative.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with HTRA2 (O43464) from PMID:32814053. HTRA2 is a mitochondrial
      serine protease involved in apoptosis.
    action: MODIFY
    reason: High-throughput neurodegenerative disease study. Unclear functional relevance.
      Generic term uninformative.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with GARS1 (P41250) from PMID:32814053. GARS1 is glycyl-tRNA
      synthetase.
    action: MODIFY
    reason: High-throughput study with no functional context. Generic &#34;protein binding&#34;
      uninformative.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with HTT/huntingtin (P42858) from neurodegenerative disease
      interactome. HTT is the protein mutated in Huntington&#39;s disease.
    action: MODIFY
    reason: From neurodegenerative disease focused screen. While potentially interesting,
      generic &#34;protein binding&#34; term is uninformative and should be replaced with
      specific molecular function.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with SPRED1 (Q7Z699) from PMID:32814053. SPRED1 is a negative
      regulator of MAPK/ERK signaling. This interaction is more plausible functionally
      since both proteins negatively regulate RTK signaling.
    action: MODIFY
    reason: While this interaction with SPRED1 has better functional plausibility
      (both are RTK signaling inhibitors), the generic &#34;protein binding&#34; term remains
      uninformative. Should use specific molecular function term.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with JPH3 (Q8WXH2) from PMID:32814053. JPH3/junctophilin-3
      is involved in junctional membrane complexes, implicated in Huntington&#39;s disease-like
      2.
    action: MODIFY
    reason: Neurodegenerative disease interactome with unclear functional connection
      to SOCS4 biology. Generic term uninformative.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  review:
    summary: Interaction with PANK2 isoform (Q9BZ23-2) from PMID:32814053. PANK2 is
      pantothenate kinase involved in CoA biosynthesis.
    action: MODIFY
    reason: High-throughput neurodegenerative disease study. No clear functional connection.
      Generic term uninformative.
    proposed_replacement_terms:
    - id: GO:0001784
      label: phosphotyrosine residue binding
    additional_reference_ids:
    - PMID:32814053
- term:
    id: GO:0016567
    label: protein ubiquitination
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  review:
    summary: SOCS4 promotes protein ubiquitination by serving as an adaptor that recruits
      E3 ubiquitin ligase machinery (Elongin B/C-Cullin-5) to bound substrates like
      activated EGFR. This is a core aspect of SOCS4&#39;s mechanism of action.
    action: ACCEPT
    reason: While this is IEA (inferred from UniPathway), it accurately represents
      SOCS4&#39;s established molecular function. The SOCS box domain recruits ubiquitin
      ligase complexes to promote degradation of receptor targets. This is well-supported
      by structural and functional studies showing SOCS4-mediated EGFR ubiquitination
      and degradation. Core mechanism annotation that should be retained.
    supported_by:
    - reference_id: SOCS4-deep-research-openai.md
      supporting_text: &#34;The SOCS box domain mediates the interaction with the Elongin
        BC complex, an adapter module in different E3 ubiquitin ligase complexes.
        This SOCS4‚ÄìElongin-Cullin complex catalyzes the polyubiquitination of the
        associated target protein, marking it for proteasomal degradation.&#34;
    - reference_id: file:human/SOCS4/SOCS4-uniprot.txt
      supporting_text: &#34;PATHWAY: Protein modification; protein ubiquitination.&#34;
- term:
    id: GO:0007175
    label: negative regulation of epidermal growth factor-activated receptor activity
  evidence_type: IDA
  original_reference_id: PMID:15590694
  review:
    summary: This is the primary, best-characterized function of SOCS4. PMID:15590694
      experimentally demonstrates that SOCS4 and SOCS5 negatively regulate EGFR signaling.
      SOCS4&#39;s SH2 domain binds phospho-Y1092 on activated EGFR, recruiting ubiquitin
      ligase machinery for receptor degradation while simultaneously blocking STAT3
      binding to that site.
    action: ACCEPT
    reason: This is the gold-standard annotation for SOCS4 - experimental IDA evidence
      from the seminal paper characterizing SOCS4/5 function in EGFR regulation. Deep
      research confirms EGFR is the primary characterized target of SOCS4. UniProt
      function section emphasizes EGFR degradation. This represents SOCS4&#39;s core molecular
      function and should be retained as a cornerstone annotation. Well-supported
      by structural studies (PMID:17997974) and functional validation.
    supported_by:
    - reference_id: SOCS4-deep-research-openai.md
      supporting_text: &#34;A defining target of SOCS4 is the Epidermal Growth Factor
        Receptor (EGFR), a receptor tyrosine kinase. SOCS4 was shown to bind directly
        to a particular phosphotyrosine site on the activated EGFR (tyrosine 1092
        in the human EGFR cytoplasmic domain) via its SH2 domain.&#34;
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping.
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: PMID:15590694
  title: Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor
    receptor signaling.
  findings: []
- id: PMID:25814554
  title: Phospho-tyrosine dependent protein-protein interaction network.
  findings: []
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
- id: PMID:32814053
  title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
    and Uncovers Widespread Protein Aggregation in Affected Brains.
  findings: []
aliases:
- Suppressor of cytokine signaling 4
- SOCS-4
core_functions:
- description: Phosphotyrosine-dependent ubiquitin ligase adaptor activity targeting
    activated EGFR for proteasomal degradation
  molecular_function:
    id: GO:0001784
    label: phosphotyrosine residue binding
  directly_involved_in:
  - id: GO:0007175
    label: negative regulation of epidermal growth factor-activated receptor activity
  - id: GO:0032436
    label: positive regulation of proteasomal ubiquitin-dependent protein catabolic
      process
  - id: GO:0016567
    label: protein ubiquitination
  - id: GO:0019221
    label: cytokine-mediated signaling pathway
  locations:
  - id: GO:0005737
    label: cytoplasm
  - id: GO:0005886
    label: plasma membrane
  substrates:
  - id: UniProtKB:P00533
    label: EGFR
  in_complex:
    id: GO:0031466
    label: Cul5-RING ubiquitin ligase complex
  supported_by:
  - reference_id: PMID:15590694
    supporting_text: SOCS4 binds directly to phosphotyrosine 1092 on activated EGFR
      via its SH2 domain, competing with STAT3 for this binding site and promoting
      EGFR degradation
  - reference_id: PMID:17997974
    supporting_text: Crystal structure reveals SOCS4 SOCS box domain recruits Elongin
      B/C complex, forming E3 ubiquitin ligase machinery that targets bound substrates
      for proteasomal degradation
  - reference_id: SOCS4-deep-research-openai.md
    supporting_text: SOCS4&#39;s SH2 domain recognizes specific phosphotyrosine motifs
      on activated EGFR (Y1092), while SOCS box recruits Elongin B/C-Cullin-5 ubiquitin
      ligase complex, catalyzing polyubiquitination and proteasomal degradation of
      EGFR. This dual mechanism both blocks STAT3 binding and promotes receptor turnover
  - reference_id: file:human/SOCS4/SOCS4-uniprot.txt
    supporting_text: Substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box
      protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination
      and subsequent proteasomal degradation of target proteins. Inhibits EGF signaling
      by mediating the degradation of the Tyr-phosphorylated EGF receptor/EGFR
status: DRAFT
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>